Kate Burbury - Concepedia

Author

Kate Burbury

Also Known As

Anne Woollett, Burbury, K, Cornelia Brauer, K Burbury, K. Burbury, Karin Boomars, Kate Burbury, Kate L. Burbury, Matteo Della Porta

155

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

Peter MacCallum Cancer Centre The University of Melbourne Monash University The Royal Melbourne Hospital St Vincent's Hospital Melbourne

About

Kate Burbury is an author at Peter MacCallum Cancer Centre specializing in medicine, oncology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	1.1K
2	Health Sciences	11	12	707
3	Public Health	4	4	116
4	Cell Biology	1	1	23
5	Classical Hematology	1	1	37

Kate Burbury

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma Constantine S. Tam, Mary Ann Anderson, Christiane Pott, New England Journal of Medicine	2018	417
Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group Theresia M. Westers, Robin Ireland, Wolfgang Kern, Leukemia Hematological MalignancyFlow CytometryMyelodysplastic SyndromesMedicineMixed-phenotype Acute Leukemia	2012	243
Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation S Kamel, Linda W. Horton, Loïc Ysebaert, Leukemia InflammationThrombosisThrombopoiesisBlood PlateletAdp-mediated Platelet Aggregation	2014	225
Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS Anna Porwit, Arjan A. van de Loosdrecht, Peter Bettelheim, Leukemia Hematological MalignancyFlow CytometryMedicineFlow Cytometry ResultsHematology	2014	145
Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib Chan Y. Cheah, Kate Burbury, Jane F. Apperley, Blood	2014	136
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma Chan Y. Cheah, Kirsten Herbert, Kacey O’Rourke, British Journal of Cancer	2014	129
Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancer Marliese Alexander, Rory Wolfe, David Ball, British Journal of Cancer	2017	93
Use of empiric antimicrobial therapy in neutropenic fever Constantine S. Tam, Małgorzata M. O’Reilly, David Andresen, Internal Medicine Journal	2011	82
Telehealth in cancer care: during and beyond the <scp>COVID</scp>‐19 pandemic Kate Burbury, Zee‐Wan Wong, Desmond Yip, Internal Medicine Journal	2021	80
Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution series Isaac Goncalves, Kate Burbury, Michael Michael, European Journal of Nuclear Medicine and Molecular Imaging Therapy-related Myeloid NeoplasmsMetastatic Neuroendocrine NeoplasiaRadiation TherapyMedicineRadionuclide Therapy	2019	61

Page 1